Key result
Compared to normal weight, overweight was associated with reduced all-cause mortality, while underweight increased mortality risk, supporting an obesity paradox in T2DM.
Why the study?
The correlations between body mass index and the risk of all-cause and cardiovascular disease mortality in patients with type 2 diabetes mellitus remain controversial.
Does body mass index (BMI) correlate with the risk of all-cause and cardiovascular disease mortality in patients with type 2 diabetes mellitus?
Meta-Analysis (n=728,321)
Does body mass index (BMI) correlate with the risk of all-cause and cardiovascular disease mortality in patients with type 2 diabetes mellitus?
Answers are grounded in this paper and cite their sources.
This meta-analysis supports the existence of an 'obesity paradox' in patients with type 2 diabetes, where overweight and mild obesity are associated with lower all-cause and cardiovascular mortality compared to normal weight.
CONTEXT: The correlations between body mass index (BMI) and risk of all-cause and cardiovascular disease (CVD) mortality in patients with type 2 diabetes mellitus (T2DM) are still controversial. OBJECTIVE: To explore the correlation between BMI and the risk of all-cause and CVD mortality in patients with T2DM. METHODS: The data sources China National Knowledge Infrastructure, Wanfang Data Knowledge Service Platform, PubMed, Web of Science, Embase, and The Cochrane Library were searched up until May 25, 2024. After adjusting for confounding factors, the original study on the association between BMI and all-cause and CVD mortality in patients with T2DM was analyzed. Number of all-cause and CVD mortality events, BMI, and basic characteristics were extracted. RESULTS: Twenty-eight papers with a total of 728 321 participants were finally included. Compared to normal-weight patients with T2DM, the risk of all-cause (HR = 1.61; 95% CI [1.51, 1.72]; P = .000) and CVD (HR = 1.31; 95% CI [1.10, 1.54]; P = .002) mortality were increased in underweight patients; however, they were reduced (HR = 0.85; 95% CI [0.81, 0.89]; P = .000) and (HR = 0.86; 95% CI [0.78, 0.96]; P = .007), respectively in patients with overweight. Also, there were significant reductions in the risk of all-cause (HR = 0.85; 95% CI [0.78, 0.92]; P = .000) and CVD (HR = 0.81; 95% CI [0.74, 0.89]; P = .000] mortality in patients with mild obesity. The difference in the risk of all-cause mortality (HR = 0.98; 95% CI [0.80, 1.21]; P = .881) in patients with moderate obesity was not statistically significant. CONCLUSION: We found that there were correlations between BMI and the risk of all-cause and CVD mortality in patients with T2DM. The obesity paradox remains.
No takes yet. Share an insight, caveat, or question.
Cui et al. (2025) conducted a meta-analysis in Type 2 diabetes mellitus (n=728,321). Body mass index (underweight, overweight, and mild obesity) vs. Normal-weight patients was evaluated on All-cause mortality (overweight vs normal-weight) (HR 0.85, 95% CI 0.81, 0.89, p=.000). Compared to normal weight, overweight was associated with reduced all-cause mortality, while underweight increased mortality risk, supporting an obesity paradox in T2DM.
Synapse has enriched 10 related papers. Consider them for comparative context: